期刊文献+

整合素对胰腺癌细胞的调节机制及其应用研究进展 被引量:1

Regulatory Mechanism of Integrins on Pancreatic Cancer Cells and Progress in their Application
下载PDF
导出
摘要 整合素作为细胞黏附受体家族成员,通过双向变构调节信号转导,介导细胞与细胞间以及细胞与细胞外基质间的黏附,并与细胞因子相互作用,参与调节胰腺癌细胞的增殖、凋亡、侵袭、迁移等生物学行为。以整合素为靶点的细胞学和动物研究表明,靶向整合素能有效提高胰腺癌的早期诊断率和药物治疗效果,这些发现为胰腺癌的临床诊治开辟了新的研究途径和发展方向。 Integrins are a family of cell adhesion receptors that mediate cell-cell and cell-extracellular matrix adhesion, and interact with cytokines through a bidirectional signal transduction,thus regulating the biological behavior of pancreatic cancer cells,such as proliferation,apoptosis,invasion,and migration etc. Molecular and animal studies indicated that integrins targeted methods might benefit the early diagnosis and drug therapy of pancreatic cancer,which offered a new approach for the study of diagnosis and treatment of pancreatic cancer.
出处 《胃肠病学》 2014年第7期436-438,共3页 Chinese Journal of Gastroenterology
关键词 整合素类 胰腺肿瘤 信号传导 Integrins Pancreatic Neoplasms Signal Transduction
  • 相关文献

参考文献6

  • 1Rolf J. Weinel,Annette Rosendahl,Elisabeth Pinschmidt,Oliver Kisker,Babette Simon,Sentot Santoso.The α 6 -integrin receptor in pancreatic carcinoma[J].Gastroenterology.1995(2) 被引量:1
  • 2Hirozumi Sawai,Hitoshi Funahashi,Yoichi Matsuo,Minoru Yamamoto,Yuji Okada,Tetsushi Hayakawa,Tadao Manabe.Expression and Prognostic Roles of Integrins and Interleukin-1 Receptor Type I in Patients with Ductal Adenocarcinoma of the Pancreas[J].Digestive Diseases and Sciences.2003(7) 被引量:1
  • 3Coert Margadant,Hanneke N Monsuur,Jim C Norman,Arnoud Sonnenberg.Mechanisms of integrin activation and trafficking[J].Current Opinion in Cell Biology.2011(5) 被引量:2
  • 4Simon L. Goodman,Martin Picard.Integrins as therapeutic targets[J].Trends in Pharmacological Sciences.2012(7) 被引量:1
  • 5余小冬,杨瑞森,于金明.整合素与肿瘤侵袭及转移的关系[J].肿瘤防治杂志,2004,11(3):317-320. 被引量:8
  • 6刘峰君,张兵波,宋歌,程英升.Gd^(3+)与RGD共修饰量子点用于胰腺癌细胞的荧光及MR双模态成像[J].高等学校化学学报,2012,33(2):378-382. 被引量:7

二级参考文献21

  • 1王瑞年,朱延波,薛建元,蔡建春.胃癌浸润转移与整合蛋白、IV型胶原酶及细胞外基质的关系[J].中华病理学杂志,1994,23(5):278-281. 被引量:37
  • 2Michalski M. H., Chen X.. Eur. J. Nucl. Med. Mol. Imag. [J], 2011,38:358-377. 被引量:1
  • 3Rudin M. , Weissleder R.. Nature Reviews Drug Discovery[J], 2003, 2:123-131. 被引量:1
  • 4Hargreaves R. J.. Clin. Pharmacol. Ther. [J], 2008, 83:349-353. 被引量:1
  • 5Arthurs O. J., Gallagher F. A.. Pediatr. Radiol. [J], 2011,41:185-98. 被引量:1
  • 6Pysz M. A., Gambhir S. S., Willmann J. K.. Clin. Radiol. [J], 2010, 65:500-516. 被引量:1
  • 7RyuJ., ParkH. Y., KimK., KimH., Yoo J. H., KangM., Im K., Grailhe R., SongR.. J. Phy. Chem. C[J], 2010, 114: 21077-21082. 被引量:1
  • 8Salerno M.. J. Nucl. Cardiol. [J] , 2010, 17:316-327. 被引量:1
  • 9Li J. J., Wang Y. A., Guo W. Z., Keay J. C., Mishima T. D., Johnson M. B., Peng X. G.. J. Am. Chem. Soc. [J], 2003, 125:12567-12575. 被引量:1
  • 10Lees E. E. , Nguyen T. L. , Clayton A. H. A. , Mulvaney P. , Muir B. W.. ACS Nano[J], 2009, 3:1121-1128. 被引量:1

共引文献14

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部